Why the study?
Does an increase in carotid total plaque area > 42.0 mm² predict the progression of subclinical polyvascular atherosclerosis and MACCE in patients aged 40-64 with cardiovascular risks?
Does an increase in carotid total plaque area > 42.0 mm² predict the progression of subclinical polyvascular atherosclerosis and MACCE in patients aged 40-64 with cardiovascular risks?
Carotid total plaque area > 42.0 mm² is an independent predictor of short-term subclinical polyvascular atherosclerosis progression and MACCE in middle-aged patients with cardiovascular risks.
Answers are grounded in this paper and cite their sources.
cTPA >42 mm² may flag higher short-term risk for surveillance; hypothesis-generating for validation in prospective cohorts.
In patients from 40 to 64 years of age with various cardiovascular risks, among the indicators of the cPB, only an increase in cTPA > 42.0 mm² was shown to be independently associated with an increase in the relative risk (RR) of progression of subclinical polyvascular atherosclerosis by 2.38 (1.08-5.25) times, as well as with the development of MACCE by 3.10 (1.54-6.26) times.
No takes yet. Share an insight, caveat, or question.
Genkel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: